cardiology
UK regulator backs Amarin’s cardiology drug Vazkepa
Amarin’s Vazkepa cardiology drug has been backed by the UK’s drugs regulator, following approval in Europe at the end of March. The Medicines and Healthcare […]
The Paradigm Shift That Wasn’t: The ISCHEMIA Trial
By ANISH KOKA A recent email that arrived in my in-box a few weeks ago from an academic hailed the latest “paradigm shift” in cardiology […]
Hillrom to buy cardiac monitoring company Bardy Diagnostics for $375M
Hillrom will buy Bardy Diagnostics, a startup that makes a wearable ECG patch, for $375 million in cash.
Boston Scientific to acquire cardiac monitoring company Preventice for $925M
Boston Scientific will acquire remote cardiac monitoring company Preventice for $925 million in cash and up to $300 million in milestone payments. The deal is […]
Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label
Boehringer and Eli Lilly have moved closer to a heart failure indication for their SGLT2 inhibitor Jardiance, as the FDA starts a fast-track review of […]
Push for better patient outcomes drives new standard of care [Sponsored]
In this webinar on Feb. 10,healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than […]
FDA rejects Novartis’ cholesterol drug after factory inspection issue
Novartis’ cholesterol drug inclisiran has hit a speed bump with the FDA, which has rejected the potential blockbuster because a manufacturing facility has yet to […]
Update on Heart Rhythm Detection Devices for Remote Patient Monitoring
Update on Heart Rhythm Detection Devices for Remote Patient Monitoring Advances in the detection of heart rhythms using medical-grade but consumer-facing remote patient monitoring – […]
Update on Heart Rhythm Detection Devices for Remote Patient Monitoring
Update on Heart Rhythm Detection Devices for Remote Patient Monitoring Top Product Reviews: Advances in the detection of heart rhythms using medical-grade but consumer-facing remote […]
Entresto set for big sales hike after FDA panel endorsement
Novartis’ Entresto is on course to become the first drug to be approved in the US for a form of heart failure that is notoriously […]
Amgen shares down as heart failure drug disappoints in phase 3 trial
Shares in Amgen were down nearly 7% after close of trading yesterday after the company’s heart failure drug omecamtiv mecarbil disappointed in a large phase […]
RHYTHM AI cleared for large trial of atrial fibrillation mapping tool
UK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, which could be used as a treatment […]
Regeneron’s cholesterol drug evinacumab claims February FDA date
The FDA has started a speedy review of Regeneron’s ANGPTL3-targeting antibody evinacumab for a rare, inherited disorder that dramatically raises the risk of heart disease. […]
Why We Need to Unlock the Full Potential of Primary Care
Why We Need to Unlock the Full Potential of Primary Care There are powerful reasons to move to a value-based primary care system. Highly effective […]
Lecithin Supplements: Understanding the Risks and Benefits
Lecithin Supplements: Understanding the Risks and Benefits Before you take lecithin supplements, you should weigh the lack of credible evidence of benefits against scientific literature […]